Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.

Education

Biotechnology

Shoreline Biosciences

Kleanthis G. Xanthopoulos

Krishna Patel

Mauro P. Avanzi

Paschalis Sideras

Charles Calderaro III

Robert Hollingsworth

Scott Forrest

Steven Neben

Vanessa Jacoby

The Research and Development team at Shoreline Biosciences focuses on advancing the company's cell therapy technology platform. Leveraging deep expertise in iPSC differentiation and genetic programming of the IL-15/CISH pathway, the team works to enhance the metabolic fitness and persistence of engineered NK Cells to improve their anti-cancer activity.

Research and Development

Scientific Research

Leadership Team

Advisory Team

��

Research and Development

About

Team members

Other teams at Shoreline Biosciences

Scientific Research

Leadership Team

Advisory Team

��������

Research and Development

About

Team members

Other teams at Shoreline Biosciences

Scientific Research

Leadership Team

Advisory Team

��